Chemotherapeutic evaluation of rifampicin to experimental bacillary dysentery in cynomolgus monkeys.
D000818:Animals; D002432:Cecum / Q000473:pathology; D003106:Colon / Q000473:pathology; D004405:Dysentery, Bacillary / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D005069:Evaluation Studies as Topic; D005243:Feces / Q000382:microbiology; D005455:Fluorescent Antibody Technique; D000882:Haplorhini; D007080:Ileocecal Valve / Q000473:pathology; D007082:Ileum / Q000473:pathology; D007413:Intestinal Mucosa / Q000473:pathology; D007612:Kanamycin / Q000627:therapeutic use; D008251:Macaca; D012007:Rectum / Q000473:pathology; D012293:Rifampin / Q000627:therapeutic use*; D012763:Shigella flexneri / Q000302:isolation & purification
D007612:Kanamycin; D012293:Rifampin